Remember that wellness is a journey, not a destination
Safety and Tolerability of the Hexadecapeptide AOD 9604 in Humans. Journal of Endocrinology & Metabolism , 2013
Important Safety Reminders Medical Supervision Required: AOD-9604 should only be used under qualified medical supervision Baseline and monitoring laboratory testing is recommended Individual contraindications and health status must be evaluated AOD-9604 is not FDA-approved for any indication Contraindications and Precautions: Pregnancy and breastfeeding (no safety data available) Active malignancy (discuss with oncologist) Pediatric use (not studied in children) Significant organ dysfunction (limited safety data) Report Concerns: Any unexpected symptoms or adverse effects should be reported to your healthcare provider promptly
These injections typically contain hydroxocobalamin or cyanocobalamin, with hydroxocobalamin being the preferred formulation in the UK as it is retained in the body for longer periods
Whilst this route is essential for treating pernicious anaemia and other malabsorption conditions, it can produce serum B12 levels far exceeding physiological requirements
These effects are essential for maintaining energy efficiency under metabolic stress, supporting research into fatigue resistance and cellular longevity